Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1665 Views
-
Last post by goellerc
-
- 0 Replies
- 1124 Views
-
Last post by ElliotB
-
- 61 Replies
- 13401 Views
-
Last post by jimmylegs
-
- 3 Replies
- 4870 Views
-
Last post by NHE
-
- 5 Replies
- 13345 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1505 Views
-
Last post by ElliotB
-
- 0 Replies
- 744 Views
-
Last post by DIM
-
- 0 Replies
- 468 Views
-
Last post by NHE
-
- 0 Replies
- 1442 Views
-
Last post by NHE